Skip to main content

Table 6 Cognitive performance and side effects of systemic treatment in relation to surgery type, based on QLQ-C30 and QLQ-BR23 questionnaire results

From: Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice

QLQ-C30Type of therapyAverageStandard deviationMedianU Manna–Whitney test
Performance scales*
 Cognitive performancechemotherapy64,4523,1163,67p = 0,031
Hormone therapy81,1621,8283,67
QLQ-BR-23Type of therapyAverageStandard deviationMedianU Manna–Whitney test
Symptom scales**
 Side effects of systemic treatmentchemotherapy58,9711,7359,00p = 0,003
Hormone therapy28,3316,1129,34